Biotecnología

Biotecnología

Exothera Launches Nucleic Acids Service Offering Powered by Ntensify
27/03/2024 - Continuous batch production of RNA service significantly cuts clinical development time while enhancing quality and yield.
Samsung Life Science Fund Invests in BrickBio
24/03/2024 - Samsung affiliates will work with BrickBio to evaluate, manufacture, and develop therapies using BrickBio's protein engineering technology.
BostonGene Named Akoya Biosciences' Qualified CRO
24/03/2024 - Will offer end-to-end spatial biology solutions to life sciences researchers for advanced spatial proteomics analysis.
ProteoNic Biosciences Partners with Ginkgo Bioworks to Support Clients
15/03/2024 - Grants Ginkgo Bioworks’ customers access to ProteoNic's vector technology.
Key Proteo to Build New CLIA-Certified Lab
11/03/2024 - Aims to expand its scope of operations to serve unaddressed newborn screening needs.
Polyplus Receives GMP Certification for Recombinant Protein & DNA Production
07/03/2024 - Also adds an additional GMP clean room for the production of GMP cell banks.
New Ways to Predict How Well Vaccines Protect Against Tuberculosis, Tularemia and Other Bacteria That Live Inside Cells
07/03/2024 - A description of Karen Elkins's research program and related publications.
Ginkgo Bioworks Acquires Patch Biosciences
29/02/2024 - Strengthens its Gene Therapy Services, Cell Therapy Services, and RNA Therapeutics Services.
VantAI, BMS Partner to Accelerate Molecular Glue Drug Discovery
22/02/2024 - Will leverage VantAI's geometric deep learning capabilities with Bristol Myers Squibb’s expertise in targeted protein degradation.
Firefly Bio Debuts with $94M Series A Funding Round
22/02/2024 - Funding will support its novel platform for treating cancer by merging antibody-drug conjugates with protein degraders.
Biognosys Opens New Proteomics Facility in MA
01/02/2024 - Expansion facilitates access to select proteomics contract research organization (CRO) services for the company’s US biopharma customers.
Entos Pharma Launches GMP Clinical Mfg. Facility in Carlsbad
30/01/2024 - Will manufacture genetic medicines based on Entos Fusogenix PLV platform, including recombinant protein, mRNA, and plasmid DNA.
Almac Sciences Extends selectAZyme Offering
25/01/2024 - Kit contains focussed library of 10 double stranded RNA Ligase enzymes selected from an extended RNAL enzyme panel.
GSK Licenses Elegen’s Cell-Free DNA Mfg. Technology
25/01/2024 - Has potential to enable a seamless transition from discovery to clinical scale-up under GMP.
AGC Biologics to Open New Manufacturing Site in Japan
19/01/2024 - Will offer preclinical through commercial services for mammalian-based protein biologics, cell therapies, and messenger RNA.
CordenPharma, pHLIP Partner on RNA & Gene Therapies
19/01/2024 - Aims to develop and manufacture small molecule drug payloads directly conjugated with (pHLIP) peptides.
Abzena Launches AbZelect Platforms for Cell Line Development
19/01/2024 - Designed to enable the rapid generation and selection of high-yielding mammalian CHO cell lines for therapeutic protein and recombinant vaccine production.
Eurofins Alphora Completes Pilot Scale mAbs Development Facility
19/01/2024 - 3,300 sq.-ft. facility dedicated to development and scaling of mAbs and other mammalian-based therapeutic proteins.
Remix, Roche Enter Small Molecule RNA Processing Pact
04/01/2024 - To develop small molecules that modulate RNA processing using Remix's REMaster drug discovery platform.
Healis, CKD Bio Ink Supply Deal to Develop Neuromodulator Protein
03/01/2024 - Aims to develop CKDB-501 for major depressive disorder and post-traumatic stress disorder.